AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28774277 — intervention group
Group type: EXPERIMENTAL
Intervention: Genomic variations in anthracycline metabolism and myocardial response to injury
Number of subjects: 1125
Study 28774277 — intervention group
Group type: EXPERIMENTAL
Intervention: Existing and novel biomarkers
Number of subjects: 1125
Study 28774277 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiographic and cardiac magnetic resonance (CMR) imaging parameters
Number of subjects: 1125
Study 28774277 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated risk-prediction model
Number of subjects: 1125
Study 28774338 — intervention group
Group type: EXPERIMENTAL
Intervention: nab-paclitaxel plus gemcitabine
Number of subjects: 52
Study 28774338 — intervention group
Group type: EXPERIMENTAL
Intervention: nab-paclitaxel 125 mg/m²
Number of subjects: 52
Study 28775115 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric hypertrophy
Number of subjects: 1282
Study 28775115 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 1282
Study 28775134 — intervention group
Group type: EXPERIMENTAL
Intervention: Prothrombin time (PT) for rivaroxaban
Number of subjects: 96
Study 28775134 — intervention group
Group type: EXPERIMENTAL
Intervention: Prothrombin time (PT) for apixaban
Number of subjects: 96
Study 28775134 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated partial thromboplastin time (aPTT) for dabigatran
Number of subjects: 96
Study 28775134 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombin time (TT) for dabigatran
Number of subjects: 96
Study 28775134 — intervention group
Group type: EXPERIMENTAL
Intervention: Reagent-specific PT and aPTT cutoffs
Number of subjects: 96
Study 28775134 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombin time (TT) cutoff for dabigatran
Number of subjects: 96
Study 28775134 — intervention group
Group type: EXPERIMENTAL
Intervention: Global coagulation tests (normal results)
Number of subjects: 96
Study 28775134 — intervention group
Group type: EXPERIMENTAL
Intervention: Reagent-specific cutoffs for global coagulation tests
Number of subjects: 96
Study 28775185 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous ECG monitoring during a marathon race
Number of subjects: 109
Study 28775185 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sensitive troponin T measurement
Number of subjects: 109
Study 28775244 — intervention group
Group type: EXPERIMENTAL
Intervention: Exhaled breath condensate (EBC) analysis in IPF patients
Number of subjects: 20
Study 28775244 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20
Study 28775245 — intervention group
Group type: EXPERIMENTAL
Intervention: Nine volatile organic compounds (VOCs) identified in exhaled breath of sarcoidosis patients; accuracy of prediction: 79.4%.
Number of subjects: 87
Study 28775245 — intervention group
Group type: COMPARATOR
Intervention: New prediction model for external validation of VOCs; accuracy of prediction: 74%.
Number of subjects: 87
Study 28775741 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 0
Study 28775900 — intervention group
Group type: EXPERIMENTAL
Intervention: CS-PFP 10
Number of subjects: 0
Study 28776147 — intervention group
Group type: EXPERIMENTAL
Intervention: Youth with DBDs
Number of subjects: 31
Study 28776147 — intervention group
Group type: COMPARATOR
Intervention: Typically developing youth
Number of subjects: 31
Study 28776320 — intervention group
Group type: EXPERIMENTAL
Intervention: New Medicine Service (NMS)
Number of subjects: 0
Study 28776320 — intervention group
Group type: COMPARATOR
Intervention: Normal Practice
Number of subjects: 0
Study 28776448 — intervention group
Group type: EXPERIMENTAL
Intervention: PNPLA3 rs738409
Number of subjects: 183
Study 28776448 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene set enrichment analysis
Number of subjects: 183
Study 28776448 — intervention group
Group type: EXPERIMENTAL
Intervention: Ingenuity Pathway Analysis
Number of subjects: 183
Study 28776718 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sinus surgery (ESS)
Number of subjects: 179
Study 28776718 — intervention group
Group type: COMPARATOR
Intervention: CMT (continued medical therapy)
Number of subjects: 179
Study 28776876 — intervention group
Group type: EXPERIMENTAL
Intervention: Mogamulizumab (defucosylated anti-CCR4 monoclonal antibody)
Number of subjects: 39
Study 28777005 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk scoring for two-year all-cause mortality risk
Number of subjects: 23489
Study 28777005 — intervention group
Group type: EXPERIMENTAL
Intervention: Identified independent mortality predictors
Number of subjects: 23489
Study 28777005 — intervention group
Group type: EXPERIMENTAL
Intervention: Developed risk-scoring system
Number of subjects: 23489
Study 28777025 — intervention group
Group type: EXPERIMENTAL
Intervention: Red-light excitation of protoporphyrin IX (PpIX) fluorescence
Number of subjects: 29
Study 28777025 — intervention group
Group type: COMPARATOR
Intervention: Conventional blue-light fluorescence
Number of subjects: 29
Study 28777755 — intervention group
Group type: EXPERIMENTAL
Intervention: ADS-5102 (amantadine) 274 mg once daily at bedtime
Number of subjects: 223
Study 28777755 — intervention group
Group type: COMPARATOR
Intervention: Placebo (previous studies)
Number of subjects: 223
Study 28777755 — intervention group
Group type: EXPERIMENTAL
Intervention: ADS-5102 (previous studies)
Number of subjects: 223
Study 28778175 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-diagnosis motivational interviewing (DDMI) and integrated group therapy (IGT)
Number of subjects: 60
Study 28778175 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 60
Study 28778282 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with PCOS (study group)
Number of subjects: 188
Study 28778282 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with hyperandrogenic PCOS (n = 76)
Number of subjects: 188
Study 28778282 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with normoandrogenic PCOS (n = 97)
Number of subjects: 188
Study 28778448 — intervention group
Group type: EXPERIMENTAL
Intervention: PF-00547659 anti-MAdCAM-1 therapy
Number of subjects: 0
Study 28778448 — intervention group
Group type: COMPARATOR
Intervention: Normal intrathecal leukocyte cell number and composition
Number of subjects: 0
Study 28778554 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Care for patients with psychotic disorders (treatment for ≥4 years)
Number of subjects: 187
Study 28778554 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with somatic comorbidity (SC)
Number of subjects: 187
Study 28778554 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with and without comorbidity
Number of subjects: 187
Study 28778611 — intervention group
Group type: COMPARATOR
Intervention: Complete vaccination cohort (2 doses of RV1)
Number of subjects: 0
Study 28778611 — intervention group
Group type: COMPARATOR
Intervention: Incomplete vaccination cohort (1 dose of RV1)
Number of subjects: 0
Study 28778612 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior influenza vaccination
Number of subjects: 141
Study 28778612 — intervention group
Group type: COMPARATOR
Intervention: No prior influenza vaccination
Number of subjects: 141
Study 28778843 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus daily text message reminders for medication adherence
Number of subjects: 84
Study 28778843 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus 4 daily text messages for exercise adherence
Number of subjects: 84
Study 28778849 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based training (SBT) curriculum of non-technical skills (NTS)
Number of subjects: 42
Study 28778849 — intervention group
Group type: COMPARATOR
Intervention: Interactive didactic sessions on colonoscopy theory and SBT
Number of subjects: 42
Study 28778946 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous electrocardiographic monitors (St. Jude CONFIRM-AF) implanted in patients
Number of subjects: 256
Study 28779015 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic risk score based on 28 variants
Number of subjects: 203
Study 28779015 — intervention group
Group type: COMPARATOR
Intervention: Conventional risk score alone
Number of subjects: 203
Study 28779469 — intervention group
Group type: EXPERIMENTAL
Intervention: Maladaptive coping strategies and locus of control (attributed to other people)
Number of subjects: 172
Study 28779469 — intervention group
Group type: COMPARATOR
Intervention: COPD severity, demographics, and depressive symptoms
Number of subjects: 172
Study 28780030 — intervention group
Group type: EXPERIMENTAL
Intervention: Lutonix 035 drug-coated balloon (DCB)
Number of subjects: 691
Study 28780401 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-concurrent functional connectivity dynamics
Number of subjects: 0
Study 28780401 — intervention group
Group type: COMPARATOR
Intervention: Resting-state functional connectivity
Number of subjects: 0
Study 28780554 — intervention group
Group type: EXPERIMENTAL
Intervention: Age at stroke onset
Number of subjects: 77
Study 28780554 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional dependency at discharge
Number of subjects: 77
Study 28780554 — intervention group
Group type: EXPERIMENTAL
Intervention: Prestroke PA
Number of subjects: 77
Study 28780579 — intervention group
Group type: EXPERIMENTAL
Intervention: CKD stage 3B
Number of subjects: 9270
Study 28780579 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialysis
Number of subjects: 9270
Study 28780579 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-fatal major atherosclerotic event
Number of subjects: 9270
Study 28780741 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 140770
Study 28780741 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 140770
Study 28780910 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative dementia care management intervention
Number of subjects: 446
Study 28780990 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC folate
Number of subjects: 278
Study 28780990 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylmalonic acid (MMA)
Number of subjects: 278
Study 28780990 — intervention group
Group type: EXPERIMENTAL
Intervention: Homocysteine
Number of subjects: 278
Study 28780990 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum folate
Number of subjects: 278
Study 28780990 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI and homocysteine
Number of subjects: 278
Study 28780990 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI and MMA
Number of subjects: 278
Study 28780990 — intervention group
Group type: EXPERIMENTAL
Intervention: Age and RBC folate
Number of subjects: 278
Study 28780991 — intervention group
Group type: EXPERIMENTAL
Intervention: Misreporting identification using fixed cut-offs for the ratio of reported energy intake and estimated energy requirement.
Number of subjects: 1199
Study 28780991 — intervention group
Group type: EXPERIMENTAL
Intervention: Over-reporting
Number of subjects: 1199
Study 28780991 — intervention group
Group type: EXPERIMENTAL
Intervention: Under-reporting
Number of subjects: 1199
Study 28780991 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean values for cut-offs in children ≤12 months
Number of subjects: 1199
Study 28780991 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean values for cut-offs in children >12 months
Number of subjects: 1199
Study 28782982 — intervention group
Group type: EXPERIMENTAL
Intervention: Polysomnography
Number of subjects: 87
Study 28782982 — intervention group
Group type: EXPERIMENTAL
Intervention: Insomnia Severity Index
Number of subjects: 87
Study 28782982 — intervention group
Group type: EXPERIMENTAL
Intervention: Pittsburgh Sleep Quality Index
Number of subjects: 87
Study 28782982 — intervention group
Group type: EXPERIMENTAL
Intervention: Dysfunctional Beliefs and Attitudes About Sleep (DBAS) questionnaire
Number of subjects: 87
Study 28782982 — intervention group
Group type: EXPERIMENTAL
Intervention: DBAS scores by sex
Number of subjects: 87
Study 28784130 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic clinical decision support system
Number of subjects: 6
Study 28784441 — intervention group
Group type: EXPERIMENTAL
Intervention: Trans-femoral TAVI with balloon post-dilation
Number of subjects: 985
Study 28784441 — intervention group
Group type: COMPARATOR
Intervention: Trans-femoral TAVI without balloon post-dilation
Number of subjects: 985
Study 28784586 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized Cognitive Training
Number of subjects: 0
Study 28784593 — intervention group
Group type: EXPERIMENTAL
Intervention: Domiciliary VR-based therapy
Number of subjects: 35
Study 28784593 — intervention group
Group type: COMPARATOR
Intervention: Control group (home-based occupational therapy)
Number of subjects: 35
Study 28784598 — intervention group
Group type: EXPERIMENTAL
Intervention: Vorinostat (100 mg twice daily) started on day -10 and continued through day +100 post-HCT with tacrolimus and methotrexate for GVHD prophylaxis.
Number of subjects: 37
Study 28784598 — intervention group
Group type: EXPERIMENTAL
Intervention: Vorinostat (100 mg twice daily) with tacrolimus and methotrexate.
Number of subjects: 37
Study 28784670 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime-Avibactam
Number of subjects: 0
Study 28784670 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 28785295 — intervention group
Group type: EXPERIMENTAL
Intervention: ~60 g/d almonds (ALM)
Number of subjects: 33
Study 28785295 — intervention group
Group type: COMPARATOR
Intervention: NCEP step II diet (CON)
Number of subjects: 33
Study 28785768 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenotype A (n=466)
Number of subjects: 882
Study 28785768 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenotype B (n=164)
Number of subjects: 882
Study 28785768 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenotype C (n=252)
Number of subjects: 882
Study 28785768 — intervention group
Group type: COMPARATOR
Intervention: Phenotype B vs A
Number of subjects: 882
Study 28785768 — intervention group
Group type: COMPARATOR
Intervention: Phenotype C vs A
Number of subjects: 882
Study 28785771 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse practitioners (NPs)
Number of subjects: 600
Study 28785771 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary care physicians (PCPs)
Number of subjects: 600
Study 28785771 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialist physicians
Number of subjects: 600
Study 28785771 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 600
Study 28786339 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative care for prisoners (n=50)
Number of subjects: 50
Study 28786339 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporary or permanent compassionate release eligibility (n=44)
Number of subjects: 50
Study 28786339 — intervention group
Group type: EXPERIMENTAL
Intervention: Request for suspension or reduction in sentence on medical grounds (n=48)
Number of subjects: 50
Study 28786987 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine patch therapy for 24 weeks in patients with minimal WMHs (group 1)
Number of subjects: 300
Study 28786987 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine patch therapy for 24 weeks in patients with moderate WMHs (group 2)
Number of subjects: 300
Study 28786987 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events rates
Number of subjects: 300
Study 28786987 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinuation due to adverse events
Number of subjects: 300
Study 28787430 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine and Docetaxel (G/D) window therapy
Number of subjects: 43
Study 28787430 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine and Docetaxel (G/D)
Number of subjects: 43
Study 28787430 — intervention group
Group type: COMPARATOR
Intervention: Standard risk (SR) patients
Number of subjects: 43
Study 28787430 — intervention group
Group type: COMPARATOR
Intervention: High risk (HR) patients
Number of subjects: 43
Study 28787430 — intervention group
Group type: COMPARATOR
Intervention: Patients aged ⩽18 years
Number of subjects: 43
Study 28787430 — intervention group
Group type: COMPARATOR
Intervention: Patients aged >18 years
Number of subjects: 43
Study 28787430 — intervention group
Group type: EXPERIMENTAL
Intervention: mP6 regimen
Number of subjects: 43
Study 28787430 — intervention group
Group type: EXPERIMENTAL
Intervention: Age at diagnosis
Number of subjects: 43
Study 28787656 — intervention group
Group type: EXPERIMENTAL
Intervention: Active suicidal ideation (SI)
Number of subjects: 269
Study 28787656 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroimaging procedure
Number of subjects: 269
Study 28787656 — intervention group
Group type: EXPERIMENTAL
Intervention: Polysomnography
Number of subjects: 269
Study 28787656 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of active SI after three days
Number of subjects: 269
Study 28787656 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraclass correlation coefficients (ICCs) for SI and pessimism
Number of subjects: 269
Study 28789693 — intervention group
Group type: EXPERIMENTAL
Intervention: PCOS mothers
Number of subjects: 21
Study 28789693 — intervention group
Group type: COMPARATOR
Intervention: Non-PCOS controls
Number of subjects: 21
Study 28789851 — intervention group
Group type: EXPERIMENTAL
Intervention: 9vHPV vaccine (4th dose)
Number of subjects: 150
Study 28789851 — intervention group
Group type: EXPERIMENTAL
Intervention: 9vHPV vaccine (3 doses)
Number of subjects: 150
Study 28790169 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline understanding of rhythm control, ablation, anticoagulation, and cardioversion
Number of subjects: 1004
Study 28790169 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month follow-up understanding of warfarin and direct oral anticoagulants (DOACs)
Number of subjects: 1004
Study 28790169 — intervention group
Group type: EXPERIMENTAL
Intervention: Understanding of oral anticoagulant benefits at diagnosis
Number of subjects: 1004
Study 28790169 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall understanding of AF treatment at 6 months
Number of subjects: 1004
Study 28791297 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 g omega-3 (OMACOR) daily
Number of subjects: 228
Study 28791297 — intervention group
Group type: COMPARATOR
Intervention: Corn oil
Number of subjects: 228
Study 28791628 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical approach using mitomycin C (MMC) at a dose of 25 mg/m
Number of subjects: 18
Study 28791628 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous approach using mitomycin C (MMC) at a dose of 25 mg/m
Number of subjects: 18
Study 28791698 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol (180 µg) administered to OCT1-deficient individuals (n=5)
Number of subjects: 39
Study 28791776 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO/FAO/UNU W
Number of subjects: 30
Study 28791776 — intervention group
Group type: EXPERIMENTAL
Intervention: Harris and Benedict, Müller and Lazzer equations
Number of subjects: 30
Study 28791776 — intervention group
Group type: EXPERIMENTAL
Intervention: De Luis equation
Number of subjects: 30
Study 28791776 — intervention group
Group type: EXPERIMENTAL
Intervention: Ireton-Jones equation
Number of subjects: 30
Study 28791776 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO/FAO/UNU W and WHO/FAO/UNU WH, Müller and Lazzer equations
Number of subjects: 30
Study 28791776 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO/FAO/UNU W and WHO/FAO/UNU WH formulas
Number of subjects: 30
Study 28792613 — intervention group
Group type: EXPERIMENTAL
Intervention: Different pressure regimes applied to healthy subjects and hospitalized patients.
Number of subjects: 0
Study 28792613 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler laser measurements of vascular flow, tissue oxygenation, and local temperature.
Number of subjects: 0
Study 28792880 — intervention group
Group type: EXPERIMENTAL
Intervention: EBV DNA in plasma samples
Number of subjects: 20174
Study 28793098 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone support (G1)
Number of subjects: 63
Study 28793098 — intervention group
Group type: COMPARATOR
Intervention: Mailing educational material (G2)
Number of subjects: 63
Study 28793152 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprachoroidal retinal prosthesis stimulation for character identification
Number of subjects: 3
Study 28793152 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprachoroidal retinal prosthesis stimulation for static image localization
Number of subjects: 3
Study 28793152 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprachoroidal retinal prosthesis stimulation for dynamic image localization
Number of subjects: 3
Study 28793152 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye tracking assessment
Number of subjects: 3
Study 28793317 — intervention group
Group type: EXPERIMENTAL
Intervention: PA/MD model
Number of subjects: 2307
Study 28793317 — intervention group
Group type: COMPARATOR
Intervention: MD model
Number of subjects: 2307
Study 28793871 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast-enhanced ultrasound (CEUS)
Number of subjects: 44
Study 28793881 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared decision-making (SDM)
Number of subjects: 810
Study 28793881 — intervention group
Group type: COMPARATOR
Intervention: Ophthalmologist-dominant decision-making (ODM)
Number of subjects: 810
Study 28793881 — intervention group
Group type: COMPARATOR
Intervention: Patient-dominant decision-making (PDM)
Number of subjects: 810
Study 28793881 — intervention group
Group type: COMPARATOR
Intervention: Older patients preferring ODM
Number of subjects: 810
Study 28793881 — intervention group
Group type: COMPARATOR
Intervention: Patients with lower education preferring ODM
Number of subjects: 810
Study 28793881 — intervention group
Group type: COMPARATOR
Intervention: Patients with higher consultation frequency preferring ODM
Number of subjects: 810
Study 28793888 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with structural leg-length discrepancy
Number of subjects: 38
Study 28793888 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 38
Study 28793888 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with shorter leg in front position
Number of subjects: 38
Study 28793888 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with shorter leg in rear position
Number of subjects: 38
Study 28793888 — intervention group
Group type: COMPARATOR
Intervention: Controls (eyes open)
Number of subjects: 38